What is sex hormone‑binding globulin (SHBG), its normal adult ranges, and how do abnormal SHBG levels influence the evaluation and management of infertility, hirsutism, or hypo‑/hyper‑androgenism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Sex Hormone-Binding Globulin (SHBG) in Clinical Practice

SHBG is a hepatic glycoprotein that binds testosterone and estradiol with high affinity, and measuring it alongside total testosterone is essential for accurately diagnosing hyperandrogenism in women with hirsutism, infertility, or PCOS, as low SHBG levels unmask elevated free testosterone even when total testosterone appears normal. 1

What is SHBG?

SHBG is a high-affinity, low-capacity binding protein synthesized by the liver that serves as the primary transport carrier for sex steroids in circulation 1. It determines the fraction of testosterone that exists in the bioactive "free" state versus protein-bound forms. The bioactive portion includes free testosterone plus a fraction of albumin-bound testosterone, while SHBG-bound testosterone is biologically inactive 1.

Physiological Regulation

SHBG levels are dynamically regulated by multiple factors:

Factors that INCREASE SHBG:

  • Estrogens (including oral contraceptives)
  • Thyroid hormones (elevated in thyrotoxicosis)
  • Hepatic cirrhosis 2, 3

Factors that DECREASE SHBG:

  • Androgens
  • Hyperinsulinemia and insulin resistance
  • Obesity (particularly central/truncal adiposity)
  • Hypothyroidism
  • Inflammatory states 1, 4

Normal Adult Ranges

Critical caveat: There is no universal standardized reference range for SHBG. Values vary significantly between assays and laboratories 1. The evidence strongly suggests that each laboratory should establish its own reference ranges rather than relying on kit manufacturer values, as using customized reference values can reclassify up to 31.6% of women with hyperandrogenic disorders who initially appeared to have normal androgen levels 5.

Typical reference ranges in adult women generally fall between 18-114 nmol/L, but this varies by assay, age, and metabolic status 6.

Clinical Significance in Hyperandrogenism

Why SHBG Matters in Diagnosis

The fundamental principle: Hirsute women commonly have relatively low SHBG levels, which causes free testosterone to be elevated even when total testosterone remains within normal limits 1. This makes free testosterone (or calculated indices incorporating SHBG) more sensitive than total testosterone alone for detecting androgen excess 1.

Recommended Diagnostic Approach for Hirsutism and Hyperandrogenism

Measure both total testosterone AND SHBG, then calculate the Free Androgen Index (FAI) 7:

FAI = (Total Testosterone / SHBG) × 100

This calculation is endorsed by multiple PCOS guidelines as the preferred method for diagnosing biochemical hyperandrogenemia 7.

Alternative approaches include:

  • Direct measurement of free testosterone by equilibrium dialysis (gold standard but not widely available)
  • Calculation of free or bioavailable testosterone from total testosterone and SHBG using validated equations 1

Important limitation: Automated testosterone assays available in most hospital laboratories often lack adequate accuracy for measuring testosterone in women 1. Specialty laboratories using liquid chromatography-tandem mass spectrometry provide superior accuracy 1.

Timing of Testing

Obtain samples during the early follicular phase (days 3-5) of the menstrual cycle, in the early morning, as testosterone levels vary by approximately 25% around the mean and are highest in early morning 1.

Clinical Applications by Condition

Polycystic Ovary Syndrome (PCOS)

Low SHBG is a hallmark finding in PCOS and serves multiple clinical roles:

  1. Diagnostic utility: SHBG measurement combined with total testosterone (as FAI) is recommended for diagnosing biochemical hyperandrogenemia in PCOS 7

  2. Metabolic marker: Low SHBG correlates with insulin resistance, hyperinsulinemia, and metabolic syndrome in PCOS patients 8, 9. It serves as a biomarker for metabolic abnormalities beyond just hyperandrogenism 10, 8

  3. Obesity connection: Obese women with PCOS have lower SHBG and higher free testosterone compared to lean PCOS women, despite similar total testosterone levels 4. This explains the greater prevalence of hirsutism in obese versus lean PCOS patients 4

Hirsutism

In evaluating hirsutism, SHBG measurement is essential because:

  • It identifies women with elevated free testosterone despite normal total testosterone 1
  • Low SHBG increases androgen bioavailability to hair follicles, worsening hirsutism 4
  • SHBG levels help predict response to estrogen-containing therapies, as estrogens raise SHBG and thereby reduce free testosterone 2

Infertility

SHBG influences fertility through multiple mechanisms:

  • Low SHBG increases free testosterone, contributing to anovulation in PCOS 8, 9
  • SHBG levels correlate with ovulatory function and menstrual regularity 4
  • Weight reduction in obese women increases SHBG, decreases free testosterone, and can restore ovulation 4

Male Hypogonadism

In men, low SHBG can mask true hypogonadism by maintaining normal total testosterone despite low free testosterone. Conversely, elevated SHBG (from aging, medications, or liver disease) can create symptoms of hypogonadism despite normal total testosterone 2, 3.

Management Implications

Therapeutic Interventions That Increase SHBG

Weight loss is the most effective non-pharmacological intervention:

  • Calorie restriction increases SHBG and decreases free testosterone 4
  • This improvement occurs secondary to reduced insulin levels 4
  • Weight reduction should be first-line therapy for obese women with PCOS-related anovulation or hirsutism 4

Pharmacological options that increase SHBG:

  • Combined oral contraceptives (estrogen component) 8
  • Metformin (improves insulin sensitivity) 8
  • GLP-1 receptor agonists 8
  • Thiazolidinediones 8

Interpreting Treatment Response

Monitor SHBG levels during treatment to assess:

  • Metabolic improvement (rising SHBG suggests improved insulin sensitivity)
  • Adequacy of androgen suppression (rising SHBG reduces free testosterone)
  • Medication adherence and efficacy 8

Common Pitfalls and How to Avoid Them

  1. Relying on total testosterone alone: Always measure SHBG concurrently to calculate free androgen indices 1

  2. Using inaccurate assays: Ensure your laboratory uses validated methods (preferably mass spectrometry) for testosterone measurement in women 1

  3. Accepting manufacturer reference ranges: Laboratories should establish population-specific reference ranges 5

  4. Ignoring timing: Sample during early follicular phase and morning hours 1

  5. Overlooking metabolic context: Low SHBG signals not just hyperandrogenism but also insulin resistance and cardiovascular risk, warranting comprehensive metabolic evaluation 10, 6, 8

  6. Missing thyroid dysfunction: Both hyperthyroidism (raises SHBG) and hypothyroidism (lowers SHBG) alter SHBG levels and can confound interpretation 10, 2, 3

Prognostic Value

Low SHBG predicts long-term health risks beyond reproductive dysfunction:

  • Increased risk of type 2 diabetes in postmenopausal women 10
  • Higher overall mortality in women with low SHBG 10
  • Cardiovascular risk (SHBG correlates positively with HDL cholesterol in men) 10
  • Non-alcoholic fatty liver disease progression 9

References

4
Research

Sex hormone-binding globulin and female reproductive function.

The Journal of steroid biochemistry and molecular biology, 1995

Related Questions

What does a sex hormone‑binding globulin (SHBG) level of 57.2 nmol/L mean for a woman planning transdermal testosterone therapy?
When should I order a serum sex hormone‑binding globulin (SHBG) level and how do I interpret low or high results in the context of hormonal imbalance?
How should low sex hormone‑binding globulin (SHBG) be evaluated and managed in a woman?
What does an elevated sex hormone‑binding globulin (SHBG) indicate and how should it be evaluated and managed?
How should I evaluate and manage low sexual desire caused by elevated sex‑hormone‑binding globulin (SHBG)?
Is a Generalized Anxiety Disorder (GAD‑7) score of 12 out of 21 considered high?
What is erythema nodosum migrans?
For a patient with respiratory failure who had a tracheostomy after 18 days and is now three days post‑tracheostomy undergoing pressure support ventilation (pressure support 15 cm H₂O, FiO₂ 40 %, PEEP 5 cm H₂O, SpO₂ 90 %, respiratory rate 5 breaths/min, tidal volume 1100 mL) and is comfortable without sedation, which ventilator adjustment is most appropriate: increase PEEP to 8 cm H₂O, increase FiO₂ to 50 %, decrease pressure support to 8 cm H₂O, or transition to spontaneous intermittent mandatory ventilation (SIMV)?
Is an Edinburgh Postnatal Depression Scale score of 14 out of 30 clinically significant?
Can a fully vaccinated patient (two documented doses of measles‑mumps‑rubella vaccine) still develop measles, and if asymptomatic after exposure, is laboratory testing needed to prevent transmission?
Which laboratory tests are indicated for a patient with a history of nephrolithiasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.